A STUDY BEFORE/AFTER THE IMPLEMENTATION OF AN ANTI-INFECTIOUS PRESCRIPTION AID - Trial NCT05140213
Access comprehensive clinical trial information for NCT05140213 through Pure Global AI's free database. This phase not specified trial is sponsored by University Hospital, Montpellier and is currently Completed. The study focuses on Sepsis,Septic Shock. Target enrollment is 371 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University Hospital, Montpellier
Timeline & Enrollment
N/A
Dec 12, 2020
Aug 30, 2021
Primary Outcome
Numbers of patient 30-day mortality
Summary
Anti-infective strategy is a major public health problem. This is a before-and-after study of
 an anti-infectious prescription tool with a comparison of mortality at 30 days (then 3 and 6
 months) between the two inclusion phases of 6 months each.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05140213
Device Trial